PLEXUS CORP SEC 10-Q Report

Plexus Corp, a leading provider of electronic manufacturing services, has released its latest Form 10-Q report, showcasing robust financial and operational performance for the quarter ended June 28, 2025. The company has demonstrated significant growth across various financial metrics and operational segments, driven by increased customer demand and successful production ramps of new products.

Financial Highlights

• Net Sales: $1,018.3 million, increased by 6.0% compared to the same period last year, driven by increased customer demand and production ramps of new products.
• Gross Profit: $103.3 million, representing a gross margin of 10.1%, up from 9.8% in the prior year, primarily due to operational efficiencies and prior restructuring activities.
• Operating Income: $53.6 million, a 36.7% increase from the previous year, with an operating margin of 5.3%, reflecting a decrease in restructuring charges and improved gross profit.
• Net Income: $45.1 million, up 79.7% from the previous year, attributed to higher operating income and reduced other expenses.
• Diluted Earnings Per Share: $1.64, compared to $0.91 in the prior year, driven by increased net income.

Business Highlights

• Revenue Segments: The company reported net sales across three primary market sectors: Aerospace/Defense, Healthcare/Life Sciences, and Industrial. The Healthcare/Life Sciences sector saw a notable increase of 10.6% in net sales for the three months ended June 28, 2025, driven by production ramps of new products and increased customer demand.
• Geographical Performance: The APAC region experienced a significant increase in net sales by 13.9% for the three months ended June 28, 2025, attributed to increased customer demand and production ramps of new products. Conversely, the EMEA region saw a decrease in net sales by 14.3% due to decreased customer demand.
• New Product Launches: The company focused on production ramps of new products for existing customers, particularly in the Aerospace/Defense and Healthcare/Life Sciences sectors, contributing to increased sales in these areas.
• Future Outlook: Management anticipates continued growth in the APAC region due to ongoing production ramps and increased customer demand. The company is also focused on operational efficiency initiatives to further improve margins and profitability.

SEC Filing: PLEXUS CORP [ PLXS ] - 10-Q - Aug. 01, 2025